EGEGazette
Live
Houthis Announce Missile Attacks on Riyadh and Saudi Aramco FacilityHouthis claim missile strikes on Saudi cities of Riyadh and YanbuHouthis claim attack on Saudi capital; smoke seen near Riyadh airportYemen's Houthis claim missile and drone strikes on Riyadh and Saudi oil facilitiesHouthis Announce Targeting of "Sensitive Sites" in Riyadh and Aramco Facility in YanbuFire at Aramco Fuel Tank Disrupts Operations at Riyadh International AirportConservative activist Charlie Kirk shot and killed at Utah university eventBlack smoke reported near Riyadh as air raid alerts sound across Saudi ArabiaUS-contracted vessel struck in Iranian attack near Strait of HormuzIran says it shot down US MQ-9 drone over Qeshm IslandUS fires dozens of interceptors against Iranian missiles targeting Jordan baseGhalibaf Announces Beginning of Era Targeting American Fighter Jets as Explosions Heard in Riyadh
sportsReported

Update: Weight-loss drugs avoid Wada banned list for 2027

A report from BBC Sport sets out the main available details, with claims kept attributed to their sources.

· 1 min read · language: en
Article image
— BBC Sport

A report from BBC Sport focuses on “Update: Weight-loss drugs avoid Wada banned list for 2027” and sets out the main development contained in the supplied source material.

Athletes is expected to not be banned from using weight-loss drugs, but the substances is expected to remain on a monitoring list.

Any statements, estimates or characterisations remain attributed to the people or organisations identified by the source. The excerpt alone does not provide a complete documentary record or necessarily include responses from every party involved.

Official statements or subsequent reporting may add context as the story develops. For now, this account is confined to information directly supported by the provided headline and excerpt.

AvoidDrugsSportsWeight Loss

Sources

EGazette summarizes reporting from multiple sources; follow the links for the originals.

Related articles

Comments

Sign in to join the conversation.

Forgot password?

No account?

Loading comments…